Product Information
TADALAFIL 2.5 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1164 per EA under NDC 62332017730. Its NADAC has been published 188 times since Jan 18, 2023.
FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332017730
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TADALAFILApproval Type
Generic (ANDA)
FDA Application
ANDA204809FDA Approved
3/26/2019
TE Code
AB1
On Market Since
3/26/2019
Pharmacological Classes
Price Statistics
The NADAC for TADALAFIL 2.5 MG TABLET has been published 188 times since Jan 18, 2023, and over the history we have for it it has declined 16.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1164 per EA |
|---|---|
| All-time high | $0.2190 (Mar 13, 2024) |
| All-time low | $0.0828 (Jul 17, 2024) |
| 52-week high | $0.1298 |
| 52-week low | $0.1143 |
| Median price | $0.1291 |
| Average price | $0.1375 |
| Largest weekly change | +53.6% (Aug 21, 2024) |
| Weeks tracked | 188 |
| Tracking since | Jan 18, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TADALAFIL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 2.5 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.1164 per EA (NDC 62332017730), effective Aug 19, 2026.
How has the price of TADALAFIL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TADALAFIL 2.5 MG TABLET has declined 16.4%. It has been tracked across 188 weekly CMS publications since Jan 18, 2023.
What are the highest and lowest recorded NADAC prices for TADALAFIL 2.5 MG TABLET?
Since Jan 18, 2023, the NADAC for TADALAFIL 2.5 MG TABLET has ranged from a low of $0.0828 (Jul 17, 2024) to a high of $0.2190 (Mar 13, 2024), with a median of $0.1291 per EA.
Are there cheaper alternatives to TADALAFIL 2.5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TADALAFIL 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TADALAFIL 2.5 MG TABLET?
TADALAFIL 2.5 MG TABLET (NDC 62332017730) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.